STOCK TITAN

[Form 4] AutoZone, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

ClearPoint Neuro, Inc. (CLPT) – Form 4 insider filing

CEO, President and Director Joseph M. Burnett reported the purchase of 1,424 common shares on 30 Jun 2025 through the company’s Employee Stock Purchase Plan (ESPP). The shares were acquired at $10.15, representing 85 % of the lower closing price on either the first or last day of the 1 Jan – 30 Jun 2025 purchase period, as permitted under the ESPP.

Following the transaction, Burnett’s direct ownership increased to 11,311 shares. He also continues to hold 243,522 shares indirectly via the Joseph M. Burnett Trust dated 20 Oct 2022.

No derivative securities were involved, and there were no dispositions reported. The filing is a routine disclosure under Section 16(a) and does not amend any prior filings. While the dollar value of the purchase (~US$14.5 k) is modest relative to Burnett’s existing indirect stake, insider buying can be viewed as a signal of management’s confidence in future prospects.

ClearPoint Neuro, Inc. (CLPT) – Comunicazione interna Modulo 4

Il CEO, Presidente e Direttore Joseph M. Burnett ha comunicato l'acquisto di 1.424 azioni ordinarie il 30 giugno 2025 tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) dell'azienda. Le azioni sono state acquistate a 10,15 $, corrispondenti all'85% del prezzo di chiusura più basso tra il primo e l'ultimo giorno del periodo di acquisto dal 1° gennaio al 30 giugno 2025, come previsto dall'ESPP.

Dopo questa operazione, la proprietà diretta di Burnett è salita a 11.311 azioni. Continua inoltre a detenere 243.522 azioni indirettamente tramite il Joseph M. Burnett Trust datato 20 ottobre 2022.

Non sono stati coinvolti strumenti derivati e non sono state segnalate cessioni. La comunicazione è una divulgazione di routine ai sensi della Sezione 16(a) e non modifica alcuna dichiarazione precedente. Sebbene il valore dell'acquisto (~14,5 mila USD) sia modesto rispetto alla partecipazione indiretta già detenuta da Burnett, l'acquisto da parte di un insider può essere interpretato come un segnale di fiducia della direzione nelle prospettive future.

ClearPoint Neuro, Inc. (CLPT) – Presentación interna Formulario 4

El CEO, Presidente y Director Joseph M. Burnett informó la compra de 1,424 acciones ordinarias el 30 de junio de 2025 a través del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. Las acciones fueron adquiridas a $10.15, lo que representa el 85% del precio de cierre más bajo entre el primer y último día del período de compra del 1 de enero al 30 de junio de 2025, según lo permitido por el ESPP.

Tras la transacción, la propiedad directa de Burnett aumentó a 11,311 acciones. Además, mantiene 243,522 acciones indirectamente a través del Joseph M. Burnett Trust fechado el 20 de octubre de 2022.

No se involucraron valores derivados ni se reportaron disposiciones. La presentación es una divulgación rutinaria bajo la Sección 16(a) y no modifica presentaciones anteriores. Aunque el valor en dólares de la compra (~14,5 mil USD) es modesto en relación con la participación indirecta existente de Burnett, la compra por parte de un insider puede interpretarse como una señal de confianza de la dirección en las perspectivas futuras.

ClearPoint Neuro, Inc. (CLPT) – 내부자 신고서 Form 4

CEO이자 사장, 이사인 Joseph M. Burnett가 2025년 6월 30일 회사의 직원 주식 구매 계획(ESPP)을 통해 1,424주 보통주를 매수했다고 보고했습니다. 주식은 $10.15에 취득되었으며, 이는 2025년 1월 1일부터 6월 30일까지의 구매 기간 중 첫날 또는 마지막 날의 최저 종가의 85%에 해당하는 가격으로 ESPP 규정에 따른 것입니다.

이번 거래 후 Burnett의 직접 소유 주식은 11,311주로 증가했습니다. 또한 그는 2022년 10월 20일자 Joseph M. Burnett Trust를 통해 243,522주를 간접적으로 보유하고 있습니다.

파생상품은 포함되지 않았으며, 처분도 보고되지 않았습니다. 이 신고는 섹션 16(a)에 따른 정기 공시이며 이전 신고를 수정하지 않습니다. 매수 금액(~미화 14,500달러)은 Burnett의 기존 간접 지분에 비해 적은 편이지만, 내부자 매수는 경영진이 미래 전망에 대해 자신감을 갖고 있음을 나타내는 신호로 볼 수 있습니다.

ClearPoint Neuro, Inc. (CLPT) – Déclaration d’initié Formulaire 4

Le PDG, Président et Directeur Joseph M. Burnett a déclaré l’achat de 1 424 actions ordinaires le 30 juin 2025 via le Plan d’Achat d’Actions Employés (ESPP) de la société. Les actions ont été acquises à 10,15 $, soit 85 % du prix de clôture le plus bas entre le premier et le dernier jour de la période d’achat du 1er janvier au 30 juin 2025, conformément aux dispositions de l’ESPP.

Après cette opération, la détention directe de Burnett est passée à 11 311 actions. Il détient également 243 522 actions indirectement via le Joseph M. Burnett Trust daté du 20 octobre 2022.

Aucun produit dérivé n’a été impliqué et aucune cession n’a été signalée. Cette déclaration est une divulgation de routine en vertu de la Section 16(a) et ne modifie aucune déclaration antérieure. Bien que la valeur d’achat (~14,5 k$ US) soit modeste par rapport à la participation indirecte existante de Burnett, cet achat d’initié peut être perçu comme un signe de confiance de la direction dans les perspectives futures.

ClearPoint Neuro, Inc. (CLPT) – Insider-Meldung Formular 4

CEO, Präsident und Direktor Joseph M. Burnett meldete den Kauf von 1.424 Stammaktien am 30. Juni 2025 über den Employee Stock Purchase Plan (ESPP) des Unternehmens. Die Aktien wurden zu 10,15 $ erworben, was 85 % des niedrigeren Schlusskurses am ersten oder letzten Tag des Kaufzeitraums vom 1. Januar bis 30. Juni 2025 entspricht, wie im ESPP erlaubt.

Nach der Transaktion erhöhte sich Burnetts direkte Beteiligung auf 11.311 Aktien. Zudem hält er weiterhin 243.522 Aktien indirekt über den Joseph M. Burnett Trust vom 20. Oktober 2022.

Es waren keine Derivate involviert und es wurden keine Veräußerungen gemeldet. Die Meldung ist eine routinemäßige Offenlegung gemäß Abschnitt 16(a) und ändert keine vorherigen Meldungen. Obwohl der Kaufwert (~14,5 Tsd. USD) im Vergleich zu Burnetts bestehendem indirektem Anteil gering ist, kann der Insider-Kauf als Zeichen des Vertrauens des Managements in die zukünftigen Aussichten gewertet werden.

Positive
  • CEO insider purchase adds 1,424 shares to direct holdings, signaling modest confidence.
  • No insider selling reported in the filing, maintaining a positive governance tone.
Negative
  • None.

Insights

TL;DR Small insider buy via ESPP; modestly positive sentiment, immaterial to float or valuation.

Burnett’s purchase increases his direct stake by roughly 14% to 11.3 k shares but remains less than 5 % of his total economic exposure when including the trust holdings. The acquisition price of $10.15 aligns with the ESPP’s 15% discount mechanism and is not indicative of open-market valuation. Given the scale (<US$15 k) and the automatic nature of ESPP participation, the transaction is unlikely to materially influence trading dynamics or the investment thesis. Nevertheless, the absence of insider selling and the continued accumulation by the CEO can be interpreted as a mild vote of confidence.

ClearPoint Neuro, Inc. (CLPT) – Comunicazione interna Modulo 4

Il CEO, Presidente e Direttore Joseph M. Burnett ha comunicato l'acquisto di 1.424 azioni ordinarie il 30 giugno 2025 tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) dell'azienda. Le azioni sono state acquistate a 10,15 $, corrispondenti all'85% del prezzo di chiusura più basso tra il primo e l'ultimo giorno del periodo di acquisto dal 1° gennaio al 30 giugno 2025, come previsto dall'ESPP.

Dopo questa operazione, la proprietà diretta di Burnett è salita a 11.311 azioni. Continua inoltre a detenere 243.522 azioni indirettamente tramite il Joseph M. Burnett Trust datato 20 ottobre 2022.

Non sono stati coinvolti strumenti derivati e non sono state segnalate cessioni. La comunicazione è una divulgazione di routine ai sensi della Sezione 16(a) e non modifica alcuna dichiarazione precedente. Sebbene il valore dell'acquisto (~14,5 mila USD) sia modesto rispetto alla partecipazione indiretta già detenuta da Burnett, l'acquisto da parte di un insider può essere interpretato come un segnale di fiducia della direzione nelle prospettive future.

ClearPoint Neuro, Inc. (CLPT) – Presentación interna Formulario 4

El CEO, Presidente y Director Joseph M. Burnett informó la compra de 1,424 acciones ordinarias el 30 de junio de 2025 a través del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. Las acciones fueron adquiridas a $10.15, lo que representa el 85% del precio de cierre más bajo entre el primer y último día del período de compra del 1 de enero al 30 de junio de 2025, según lo permitido por el ESPP.

Tras la transacción, la propiedad directa de Burnett aumentó a 11,311 acciones. Además, mantiene 243,522 acciones indirectamente a través del Joseph M. Burnett Trust fechado el 20 de octubre de 2022.

No se involucraron valores derivados ni se reportaron disposiciones. La presentación es una divulgación rutinaria bajo la Sección 16(a) y no modifica presentaciones anteriores. Aunque el valor en dólares de la compra (~14,5 mil USD) es modesto en relación con la participación indirecta existente de Burnett, la compra por parte de un insider puede interpretarse como una señal de confianza de la dirección en las perspectivas futuras.

ClearPoint Neuro, Inc. (CLPT) – 내부자 신고서 Form 4

CEO이자 사장, 이사인 Joseph M. Burnett가 2025년 6월 30일 회사의 직원 주식 구매 계획(ESPP)을 통해 1,424주 보통주를 매수했다고 보고했습니다. 주식은 $10.15에 취득되었으며, 이는 2025년 1월 1일부터 6월 30일까지의 구매 기간 중 첫날 또는 마지막 날의 최저 종가의 85%에 해당하는 가격으로 ESPP 규정에 따른 것입니다.

이번 거래 후 Burnett의 직접 소유 주식은 11,311주로 증가했습니다. 또한 그는 2022년 10월 20일자 Joseph M. Burnett Trust를 통해 243,522주를 간접적으로 보유하고 있습니다.

파생상품은 포함되지 않았으며, 처분도 보고되지 않았습니다. 이 신고는 섹션 16(a)에 따른 정기 공시이며 이전 신고를 수정하지 않습니다. 매수 금액(~미화 14,500달러)은 Burnett의 기존 간접 지분에 비해 적은 편이지만, 내부자 매수는 경영진이 미래 전망에 대해 자신감을 갖고 있음을 나타내는 신호로 볼 수 있습니다.

ClearPoint Neuro, Inc. (CLPT) – Déclaration d’initié Formulaire 4

Le PDG, Président et Directeur Joseph M. Burnett a déclaré l’achat de 1 424 actions ordinaires le 30 juin 2025 via le Plan d’Achat d’Actions Employés (ESPP) de la société. Les actions ont été acquises à 10,15 $, soit 85 % du prix de clôture le plus bas entre le premier et le dernier jour de la période d’achat du 1er janvier au 30 juin 2025, conformément aux dispositions de l’ESPP.

Après cette opération, la détention directe de Burnett est passée à 11 311 actions. Il détient également 243 522 actions indirectement via le Joseph M. Burnett Trust daté du 20 octobre 2022.

Aucun produit dérivé n’a été impliqué et aucune cession n’a été signalée. Cette déclaration est une divulgation de routine en vertu de la Section 16(a) et ne modifie aucune déclaration antérieure. Bien que la valeur d’achat (~14,5 k$ US) soit modeste par rapport à la participation indirecte existante de Burnett, cet achat d’initié peut être perçu comme un signe de confiance de la direction dans les perspectives futures.

ClearPoint Neuro, Inc. (CLPT) – Insider-Meldung Formular 4

CEO, Präsident und Direktor Joseph M. Burnett meldete den Kauf von 1.424 Stammaktien am 30. Juni 2025 über den Employee Stock Purchase Plan (ESPP) des Unternehmens. Die Aktien wurden zu 10,15 $ erworben, was 85 % des niedrigeren Schlusskurses am ersten oder letzten Tag des Kaufzeitraums vom 1. Januar bis 30. Juni 2025 entspricht, wie im ESPP erlaubt.

Nach der Transaktion erhöhte sich Burnetts direkte Beteiligung auf 11.311 Aktien. Zudem hält er weiterhin 243.522 Aktien indirekt über den Joseph M. Burnett Trust vom 20. Oktober 2022.

Es waren keine Derivate involviert und es wurden keine Veräußerungen gemeldet. Die Meldung ist eine routinemäßige Offenlegung gemäß Abschnitt 16(a) und ändert keine vorherigen Meldungen. Obwohl der Kaufwert (~14,5 Tsd. USD) im Vergleich zu Burnetts bestehendem indirektem Anteil gering ist, kann der Insider-Kauf als Zeichen des Vertrauens des Managements in die zukünftigen Aussichten gewertet werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hackney William R.

(Last) (First) (Middle)
123 S. FRONT STREET
DEPT. 8074

(Street)
MEMPHIS TN 38103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AUTOZONE INC [ AZO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 06/30/2025 A 1 A $3,712.23 96.9263 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired pursuant to AutoZone, Inc. Sixth Amended and Restated Executive Stock Purchase Plan.
/s/ William R. Hackney 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CLPT shares did the CEO purchase on 30 Jun 2025?

Joseph M. Burnett acquired 1,424 common shares under the ESPP.

At what price were the shares bought according to the Form 4?

The ESPP purchase price was $10.15 per share (85 % of the reference market price).

What is the CEO’s total direct shareholding after the transaction?

Burnett now directly owns 11,311 CLPT shares.

Does the CEO hold additional shares indirectly?

Yes. Through a trust, he indirectly holds 243,522 shares.

Were any derivative securities involved in this filing?

No derivative securities were reported in Table II.
Autozone

NYSE:AZO

AZO Rankings

AZO Latest News

AZO Latest SEC Filings

AZO Stock Data

58.92B
16.67M
0.31%
95.04%
1.73%
Specialty Retail
Retail-auto & Home Supply Stores
Link
United States
MEMPHIS